Results 121 to 130 of about 31,379 (226)

Eltrombopag-Associated Hyperpigmentation [PDF]

JAMA Dermatology, 2013
Inbal, Braunstein, Karolyn A, Wanat, Rosalie, Elenitsas, Xiaowei, Xu, Noelle, Frey, Misha, Rosenbach   +5 more
openaire   +2 more sources

Bioactive Phytochemical Compounds in Medicago sativa L. (Alfalfa): A Systematic Review of Biological Properties and Therapeutic Relevance in Nutraceutical and Functional Food Implications

Food Frontiers, Volume 7, Issue 2, March 2026.
ABSTRACT Medicago sativa L. (alfalfa) harbors a remarkably diverse reservoir of bioactive secondary metabolites. Flavonoids, isoflavones, and triterpenoid saponins dominate its bioactivity landscape, driving potent antioxidant, anti‐inflammatory, antimicrobial, estrogenic, hypolipidemic, and cytotoxic actions through redox modulation, membrane ...
Parham Joolaei Ahranjani, Hamid Rashidi Nodeh, Zahra Esfandiari, Giovanna Ferrentino   +3 more
wiley   +1 more source

Applicability of Novel Laser Scanning Microscopy Techniques in Demonstrating Characteristic Features of Porokeratosis: In Vivo and Ex Vivo Investigation

JEADV Clinical Practice, Volume 5, Issue 1, Page 91-100, March 2026.
Porokeratoses, used here as an example of keratinization disorders, are marked by cornoid lamella and linked to skin cancer risk, making accurate diagnosis essential. This study compared conventional methods, dermoscopy, and histopathology, with advanced imaging using reflectance confocal microscopy (RCM) and multiphoton microscopy (MPM).
Rahime Inci, Noora Neittaanmäki, Jeemol James, Marica B. Ericson, Sirkku Peltonen, Despoina Kantere   +5 more
wiley   +1 more source

Low Dose Pegylated Interferon Alpha as a First‐Line Treatment for Necrobiotic Xanthogranuloma

JEADV Clinical Practice, Volume 5, Issue 1, Page 215-218, March 2026.
ABSTRACT Necrobiotic xanthogranuloma (NXG) is a rare, progressive granulomatous disorder frequently associated with monoclonal gammopathy, particularly monoclonal gammopathy of undetermined significance (MGUS). It typically presents with indurated to ulcerative yellowish plaques or nodules, often with ocular involvement.
Ishana Dixit, Charmaine Vanessa S. Chamberlin, Pablo Fernandez‐Peñas   +2 more
wiley   +1 more source

Hyaluronic Acid, Succinic Acid, and Exosomes in the Treatment of Facial Hyperpigmentation: A Report of Two Cases. [PDF]

Cureus
Corvalan V, Mercado V, Amin M.
europepmc   +1 more source

Minocycline-Induced Hyperpigmentation

Journal of Osteopathic Medicine, 2018
Leonid, Skorin, Stephanie, Norberg
openaire   +2 more sources

Skin Hyperpigmentation as Initial Manifestation of Vitamin B₁₂ Deficiency: A Case of Delayed Diagnosis With Late-Onset Subacute Combined Degeneration of the Cord. [PDF]

Case Rep Med
Adjei P, Manu KO, Asante Addison PK, Ntow E.   +3 more
europepmc   +1 more source

Daunorubicin‐induced hyperpigmentation [PDF]

British Journal of Haematology, 2010
Raj R, Pol, Andrew, Wright, Anita, Hill
openaire   +2 more sources

Tranexamic Acid for Hyperpigmentation Disorders: A Literature Review on Efficacy and Safety in Melasma and PIH. [PDF]

J Cosmet Dermatol
AlJabr A, AlAnazi AMI, AlEtebi RAA.
europepmc   +1 more source

Dupilumab Treatment in Pemphigus: A Report of Three Cases and Literature Review

JEADV Clinical Practice, Volume 5, Issue 1, Page 254-257, March 2026.
Capsule summary Pemphigus vulgaris and foliaceus are rare autoimmune blistering diseases traditionally treated with corticosteroids, immunosuppressants, intravenous immunoglobulins, and rituximab. A subset of patients remains refractory or has contraindications to these conventional therapies. We present three cases of pemphigus treated with dupilumab.
José Javier Mateos Rico, Marta Gutiérrez Pascual, María Dolores Caro Gutiérrez, Cristina Marcos Rodríguez, Javier de Quadros Malagón, Francisco Javier Vicente Martín   +5 more
wiley   +1 more source